Faculty Opinions recommendation of Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1161194.622576 ◽

2009 ◽

Author(s):

Elaine Sloand

Keyword(s):

High Risk ◽

Myelodysplastic Syndromes ◽

Phase 2 ◽

Efficacy And Safety ◽

Phase 2 Study ◽

5Q Deletion

Download Full-text

Updated Results from Phase 2 Study of Guadecitabine for Patients with Untreated INT-2/High Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Leukemia Research ◽

10.1016/s0145-2126(17)30152-2 ◽

2017 ◽

Vol 55 ◽

pp. S25-S26 ◽

Cited By ~ 1

Author(s):

G. Montalban-Bravo ◽

B. Prithviraj ◽

Y. Alvarado ◽

N. Daver ◽

F. Ravandi ◽

...

Keyword(s):

High Risk ◽

Myelodysplastic Syndromes ◽

Chronic Myelomonocytic Leukemia ◽

Phase 2 ◽

Phase 2 Study ◽

Myelomonocytic Leukemia

Download Full-text

A phase 2 study of the efficacy and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent Myelodysplastic Syndromes

http://isrctn.org/> ◽

10.1186/isrctn62162141 ◽

2013 ◽

Author(s):

Dominic Culligan

Keyword(s):

Myelodysplastic Syndromes ◽

Iron Loading ◽

Phase 2 ◽

Efficacy And Safety ◽

Phase 2 Study

Download Full-text

A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis

Case Medical Research ◽

10.31525/ct1-nct03911713 ◽

2019 ◽

Author(s):

Keyword(s):

Cystic Fibrosis ◽

Phase 2 ◽

Efficacy And Safety ◽

Phase 2 Study

Download Full-text

Faculty Opinions recommendation of An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718028323.793480222 ◽

2013 ◽

Author(s):

Richard Riedel

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase 2 ◽

Efficacy And Safety ◽

Open Label ◽

Phase 2 Study ◽

Open Label Phase ◽

Metastatic Soft Tissue Sarcoma ◽

Previously Treated

Download Full-text

Faculty Opinions recommendation of Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718390800.793495363 ◽

2014 ◽

Author(s):

James Bussel

Keyword(s):

Immune Thrombocytopenic Purpura ◽

Phase 2 ◽

Efficacy And Safety ◽

Thrombocytopenic Purpura ◽

Chronic Immune Thrombocytopenic Purpura ◽

Multicenter Phase ◽

Phase 2 Study

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734506216.793579336 ◽

2020 ◽

Author(s):

Nathalie Gaspar

Keyword(s):

Adult Patients ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Metastatic Osteosarcoma ◽

Phase 2 Study

Download Full-text

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study

The Lancet Oncology ◽

10.1016/s1470-2045(14)70335-3 ◽

2014 ◽

Vol 15 (10) ◽

pp. 1090-1099 ◽

Cited By ~ 246

Author(s):

Jan A Burger ◽

Michael J Keating ◽

William G Wierda ◽

Elena Hartmann ◽

Julia Hoellenriegel ◽

...

Keyword(s):

High Risk ◽

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Phase 2 ◽

Phase 2 Study

Download Full-text

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

The Lancet Oncology ◽

10.1016/s1470-2045(21)00056-5 ◽

2021 ◽

Author(s):

Robert L Coleman ◽

Domenica Lorusso ◽

Christine Gennigens ◽

Antonio González-Martín ◽

Leslie Randall ◽

...

Keyword(s):

Cervical Cancer ◽

Phase 2 ◽

Efficacy And Safety ◽

Open Label ◽

Phase 2 Study ◽

Previously Treated

Download Full-text

Efficacy and safety of s201086/GLPG1972, an ADAMTS-5 inhibitor, in patients with knee osteoarthritis: roccella, a 52-week, randomized, double-blind, dose-ranging phase 2 study

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2021.02.348 ◽

2021 ◽

Vol 29 ◽

pp. S264

Author(s):

T.J. Schnitzer ◽

M. Pueyo ◽

H. Deckx ◽

E. van der Aar ◽

K. Bernard ◽

...

Keyword(s):

Knee Osteoarthritis ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Phase 2 Study ◽

Dose Ranging

Download Full-text

28588 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a randomized, double-blind, vehicle-controlled phase 2 study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.213 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB47

Author(s):

Matthew Zirwas ◽

Zoe D. Draelos ◽

Janet DuBois ◽

Leon Kircik ◽

Angela Moore ◽

...

Keyword(s):

Seborrheic Dermatitis ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Phase 2 Study

Download Full-text